{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:30:56Z","timestamp":1792647056414,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7845","license":[{"start":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T00:00:00Z","timestamp":1608076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T00:00:00Z","timestamp":1608076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2021,2,11]]},"DOI":"10.1038\/s41586-020-03047-0","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T17:09:05Z","timestamp":1608138545000},"page":"315-319","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":130,"title":["Antidepressant actions of ketamine engage cell-specific translation via eIF4E"],"prefix":"10.1038","volume":"590","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2272-1138","authenticated-orcid":false,"given":"Argel","family":"Aguilar-Valles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8623-0661","authenticated-orcid":false,"given":"Danilo","family":"De Gregorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edna","family":"Matta-Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad J.","family":"Eslamizade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdessattar","family":"Khlaifia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Skaleka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Lopez-Canul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4740-0293","authenticated-orcid":false,"given":"Angelica","family":"Torres-Berrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bermudez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth M.","family":"Rurak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Simard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalina","family":"Salmaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4124-9825","authenticated-orcid":false,"given":"Gabriella","family":"Gobbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4056-0574","authenticated-orcid":false,"given":"Jean-Claude","family":"Lacaille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4707-8759","authenticated-orcid":false,"given":"Nahum","family":"Sonenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,16]]},"reference":[{"key":"3047_CR1","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush, A. J. et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry 163, 1905\u20131917 (2006).","journal-title":"Am. J. Psychiatry"},{"key":"3047_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/bja\/77.4.441","volume":"77","author":"K Hirota","year":"1996","unstructured":"Hirota, K. & Lambert, D. G. Ketamine: its mechanism(s) of action and unusual clinical uses. Br. J. Anaesth. 77, 441\u2013444 (1996).","journal-title":"Br. J. Anaesth."},{"key":"3047_CR3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1124\/mol.61.3.533","volume":"61","author":"K Kashiwagi","year":"2002","unstructured":"Kashiwagi, K. et al. Channel blockers acting at N-methyl-d-aspartate receptors: differential effects of mutations in the vestibule and ion channel pore. Mol. Pharmacol. 61, 533\u2013545 (2002).","journal-title":"Mol. Pharmacol."},{"key":"3047_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman, R. M. et al. Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 47, 351\u2013354 (2000).","journal-title":"Biol. Psychiatry"},{"key":"3047_CR5","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate Jr","year":"2006","unstructured":"Zarate, C. A., Jr et al. A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry 63, 856\u2013864 (2006).","journal-title":"Arch. Gen. Psychiatry"},{"key":"3047_CR6","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.biopsych.2014.03.026","volume":"76","author":"KA Lapidus","year":"2014","unstructured":"Lapidus, K. A. et al. A randomized controlled trial of intranasal ketamine in major depressive disorder. Biol. Psychiatry 76, 970\u2013976 (2014).","journal-title":"Biol. Psychiatry"},{"key":"3047_CR7","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/mp.2016.249","volume":"22","author":"CA Zarate Jr","year":"2017","unstructured":"Zarate, C. A., Jr & Machado-Vieira, R. Ketamine: translating mechanistic discoveries into the next generation of glutamate modulators for mood disorders. Mol. Psychiatry 22, 324\u2013327 (2017).","journal-title":"Mol. Psychiatry"},{"key":"3047_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/mp.2017.225","volume":"23","author":"ER Workman","year":"2018","unstructured":"Workman, E. R., Niere, F. & Raab-Graham, K. F. Engaging homeostatic plasticity to treat depression. Mol. Psychiatry 23, 26\u201335 (2018).","journal-title":"Mol. Psychiatry"},{"key":"3047_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature17998","volume":"533","author":"P Zanos","year":"2016","unstructured":"Zanos, P. et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 533, 481\u2013486 (2016).","journal-title":"Nature"},{"key":"3047_CR10","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1190287","volume":"329","author":"N Li","year":"2010","unstructured":"Li, N. et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329, 959\u2013964 (2010).","journal-title":"Science"},{"key":"3047_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1073\/pnas.1814709116","volume":"116","author":"K Fukumoto","year":"2019","unstructured":"Fukumoto, K. et al. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine. Proc. Natl Acad. Sci. USA 116, 297\u2013302 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3047_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","volume":"169","author":"RA Saxton","year":"2017","unstructured":"Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell 169, 361\u2013371 (2017).","journal-title":"Cell"},{"key":"3047_CR13","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.cell.2009.01.042","volume":"136","author":"N Sonenberg","year":"2009","unstructured":"Sonenberg, N. & Hinnebusch, A. G. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136, 731\u2013745 (2009).","journal-title":"Cell"},{"key":"3047_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neuropharm.2015.07.028","volume":"100","author":"OH Miller","year":"2016","unstructured":"Miller, O. H., Moran, J. T. & Hall, B. J. Two cellular hypotheses explaining the initiation of ketamine\u2019s antidepressant actions: direct inhibition and disinhibition. Neuropharmacology 100, 17\u201326 (2016).","journal-title":"Neuropharmacology"},{"key":"3047_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/npp.2017.210","volume":"43","author":"ET Kavalali","year":"2018","unstructured":"Kavalali, E. T. & Monteggia, L. M. The ketamine metabolite 2R,6R-hydroxynorketamine blocks NMDA receptors and impacts downstream signaling linked to antidepressant effects. Neuropsychopharmacology 43, 221\u2013222 (2018).","journal-title":"Neuropsychopharmacology"},{"key":"3047_CR16","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/nature22084","volume":"546","author":"K Suzuki","year":"2017","unstructured":"Suzuki, K., Nosyreva, E., Hunt, K. W., Kavalali, E. T. & Monteggia, L. M. Effects of a ketamine metabolite on synaptic NMDAR function. Nature 546, E1\u2013E3 (2017).","journal-title":"Nature"},{"key":"3047_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/ALN.0000000000000285","volume":"121","author":"RK Paul","year":"2014","unstructured":"Paul, R. K. et al. (R,S)-Ketamine metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine increase the mammalian target of rapamycin function. Anesthesiology 121, 149\u2013159 (2014).","journal-title":"Anesthesiology"},{"key":"3047_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.biopsych.2017.11.028","volume":"84","author":"C Adaikkan","year":"2018","unstructured":"Adaikkan, C., Taha, E., Barrera, I., David, O. & Rosenblum, K. Calcium\/calmodulin-dependent protein kinase II and eukaryotic elongation factor 2 kinase pathways mediate the antidepressant action of ketamine. Biol. Psychiatry 84, 65\u201375 (2018).","journal-title":"Biol. Psychiatry"},{"key":"3047_CR19","doi-asserted-by":"publisher","unstructured":"Miller, O. H., Grabole, N., Wells, I. & Hall, B. Genome-wide translating mRNA analysis following ketamine reveals novel targets for antidepressant treatment. Preprint at https:\/\/doi.org\/10.1101\/254904 (2018).","DOI":"10.1101\/254904"},{"key":"3047_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","volume":"74","author":"JW Murrough","year":"2013","unstructured":"Murrough, J. W. et al. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol. Psychiatry 74, 250\u2013256 (2013).","journal-title":"Biol. Psychiatry"},{"key":"3047_CR21","unstructured":"Aguilar-Valles, A., Matta-Camacho, E. & Sonenberg, N. in The Oxford Handbook of Neuronal Protein Synthesis (ed. Wayne Sossin) (Oxford Univ. Press, 2018)."},{"key":"3047_CR22","doi-asserted-by":"publisher","first-page":"9581","DOI":"10.1523\/JNEUROSCI.2423-05.2005","volume":"25","author":"JL Banko","year":"2005","unstructured":"Banko, J. L. et al. The translation repressor 4E-BP2 is critical for eIF4F complex formation, synaptic plasticity, and memory in the hippocampus. J. Neurosci. 25, 9581\u20139590 (2005).","journal-title":"J. Neurosci."},{"key":"3047_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature10130","volume":"475","author":"AE Autry","year":"2011","unstructured":"Autry, A. E. et al. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475, 91\u201395 (2011).","journal-title":"Nature"},{"key":"3047_CR24","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1172\/JCI130808","volume":"130","author":"DM Gerhard","year":"2020","unstructured":"Gerhard, D. M. et al. GABA interneurons are the cellular trigger for ketamine\u2019s rapid antidepressant actions. J. Clin. Invest. 130, 1336\u20131349 (2020).","journal-title":"J. Clin. Invest."},{"key":"3047_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neuron.2019.03.013","volume":"102","author":"RS Duman","year":"2019","unstructured":"Duman, R. S., Sanacora, G. & Krystal, J. H. Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron 102, 75\u201390 (2019).","journal-title":"Neuron"},{"key":"3047_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0321-5","volume":"8","author":"LHL Ng","year":"2018","unstructured":"Ng, L. H. L. et al. Ketamine and selective activation of parvalbumin interneurons inhibit stress-induced dendritic spine elimination. Transl. Psychiatry 8, 272 (2018).","journal-title":"Transl. Psychiatry"},{"key":"3047_CR27","doi-asserted-by":"publisher","first-page":"E3007","DOI":"10.1073\/pnas.1718883115","volume":"115","author":"AJ Widman","year":"2018","unstructured":"Widman, A. J. & McMahon, L. L. Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy. Proc. Natl Acad. Sci. USA 115, E3007\u2013E3016 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3047_CR28","doi-asserted-by":"crossref","first-page":"eaat8078","DOI":"10.1126\/science.aat8078","volume":"364","author":"RN Moda-Sava","year":"2019","unstructured":"Moda-Sava, R. N. et al. Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation. Science 364, eaat8078 (2019).","journal-title":"Science"},{"key":"3047_CR29","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature25509","volume":"554","author":"Y Yang","year":"2018","unstructured":"Yang, Y. et al. Ketamine blocks bursting in the lateral habenula to rapidly relieve depression. Nature 554, 317\u2013322 (2018).","journal-title":"Nature"},{"key":"3047_CR30","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.molcel.2010.02.022","volume":"37","author":"M Bidinosti","year":"2010","unstructured":"Bidinosti, M. et al. Postnatal deamidation of 4E-BP2 in brain enhances its association with raptor and alters kinetics of excitatory synaptic transmission. Mol. Cell 37, 797\u2013808 (2010).","journal-title":"Mol. Cell"},{"key":"3047_CR31","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature11628","volume":"493","author":"CG Gkogkas","year":"2013","unstructured":"Gkogkas, C. G. et al. Autism-related deficits via dysregulated eIF4E-dependent translational control. Nature 493, 371\u2013377 (2013).","journal-title":"Nature"},{"key":"3047_CR32","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.pnpbp.2011.05.010","volume":"35","author":"CS Jernigan","year":"2011","unstructured":"Jernigan, C. S. et al. The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 1774\u20131779 (2011).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"3047_CR33","doi-asserted-by":"publisher","unstructured":"Abdallah, C. et al. Rapamycin, an immunosuppressant and mTORC1 inhibitor, triples the antidepressant response rate of ketamine at 2 weeks following treatment: a double-blind, placebo-controlled, cross-over, randomized clinical trial. Preprint at https:\/\/doi.org\/10.1101\/500959 (2018).","DOI":"10.1101\/500959"},{"key":"3047_CR34","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/nm1001-1128","volume":"7","author":"K Tsukiyama-Kohara","year":"2001","unstructured":"Tsukiyama-Kohara, K. et al. Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1. Nat. Med. 7, 1128\u20131132 (2001).","journal-title":"Nat. Med."},{"key":"3047_CR35","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/BF00181937","volume":"95","author":"SR Bodnoff","year":"1988","unstructured":"Bodnoff, S. R., Suranyi-Cadotte, B., Aitken, D. H., Quirion, R. & Meaney, M. J. The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology (Berl.) 95, 298\u2013302 (1988).","journal-title":"Psychopharmacology (Berl.)"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41586-020-03047-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-020-03047-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-020-03047-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:01:44Z","timestamp":1684620104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-020-03047-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,16]]},"references-count":35,"journal-issue":{"issue":"7845","published-print":{"date-parts":[[2021,2,11]]}},"alternative-id":["3047"],"URL":"https:\/\/doi.org\/10.1038\/s41586-020-03047-0","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,16]]},"assertion":[{"value":"3 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}